cadila

With talks underway between the central government and Zydus Cadila over the pricing of the COVID-19 vaccine ZyCov-D,…

New Delhi, October 3 With talks underway between the central government and Zydus Cadila over the pricing of the Covid-19 vaccine ZyCov-D,…

BSE Sensex and Nifty 50 were set to witness a gap-down start today. (Image: REUTERS)Nifty futures extended losses, were now trading 162 points or 0.92 per cent down at 17439.50 on the…

NEW DELHI: Despite being the first one to get emergency approval for its needle-free Covid vaccine for adolescents in India, shares of have not reacted much. Analysts do see a lift to its…

According to Patel, Zydus Cadila had invested Rs 500 crore in developing the vaccine and in the manufacturing capacity with further investments expected as manufacturing capacity was being…

A day after emergency use approval was granted to the Zydus Cadila Covid-19 vaccine, the pharma major has said that the price of the vaccine will be decided by next week. Managing Director…

An additional advantage with the Zydus Cadila vaccine is the fact that it is needle-free and thereby reduces the body pain and other side effects that are experienced with other…

If regulators consent, ZyCoV-D could become the second home-grown shot, after Bharat Biotech's Covaxin; and fourth to get a DCGI nod for use against the viral infection in India after…

India is vaccinating on an average 50 lakh individuals daily since June 21, equivalent to inoculating the entire population of Norway every day, the Centre said on Friday and asserted that…

The Phase 3 trials on more than 28,000 volunteers across 50 clinical sites, have shown an efficacy rate of 66.6%. That is lower than the efficacy levels of vaccines from Moderna and…